You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Sebetralstat for treating acute attacks of hereditary angioedema in people aged 12 and over [ID6284]

  • In development
  • Reference number: GID-TA11334
  • Expected publication date:  17 December 2025

Register as a stakeholder

  • Project information
  • Project documents

On this page

  1. Draft guidance: 1
  2. Declaration of interests
  3. Invitation to participate
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6284

Documents

Documents created during the development process.

Draft guidance: 1

  • Draft guidance: 1

  • Draft guidance (downloadable version) (PDF 310 KB)

    Published:
    04 November 2025
  • Draft guidance (online commenting)

  • Committee papers (PDF 6.46 MB)

    Published:
    04 November 2025
  • Public committee slides (PDF 1.36 MB)

    Published:
    04 November 2025
  • Equality impact assessment (downloadable version) (PDF 166 KB)

    Published:
    04 November 2025

Declaration of interests

  • Register of interests (PDF 149 KB)

    Published:
    18 November 2025

Invitation to participate

  • Final scope (PDF 122 KB)

    Published:
    14 March 2025
  • Final stakeholder list (PDF 135 KB)

    Published:
    14 March 2025
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 199 KB)

    Published:
    14 March 2025
  • Equality impact assessment (scoping) (PDF 105 KB)

    Published:
    14 March 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6284

  • Draft scope post referral (PDF 168 KB)

    Published:
    28 June 2024
  • Draft matrix post referral (PDF 179 KB)

    Published:
    28 June 2024
Back to top